최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.25 no.1, 2007년, pp.16 - 25
이석호 (가천의과학대학교 의학전문대학원 방사선종양학교실) , 최진호 (가천의과학대학교 의학전문대학원 방사선종양학교실) , 이영돈 (가천의과학대학교 의학전문대학원 외과학교실) , 박흥규 (가천의과학대학교 의학전문대학원 외과학교실) , 김현영 (가천의과학대학교 의학전문대학원 외과학교실) , 박세훈 (가천의과학대학교 의학전문대학원 내과학교실) , 이규찬 (가천의과학대학교 의학전문대학원 방사선종양학교실)
[
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6- year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996;348:708- 713
Liljegren G, Holmberg L, Bergh J, et al. 10- Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17:2326- 2333
Fisher B, Anderson S, Bryant J, et al. Twenty- year follow- up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233- 1241
Veronesi U, Cascinelli N, Mariani L, et al. Twenty- year follow- up of a randomized study comparing breast- conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227- 1232
Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen- year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697- 702
Sacchini V, Luini A, Tana S, et al. Quantitive and qualitive consmetic evaluation after conservative treatment for breast cancer. Eur J Cancer 1991;27:1395- 1400
Dewar JA, Benhamou S, Benhamou E, et al. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers. Radiother Oncol 1988;12: 273- 280
Kim BK, Shin SS, Kim SD, Noh DY, Ha SH. Cosmetic results of conservative early breast cancer. J Korean Soc Ther Radiol 2001;19:21- 26
Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the breast. 1st ed. Philadelphia; Lippincott- Raven, 1996:461
Komoike Y, Motomura K, Inaji H, et al. Long term results of breast conserving surgery for stage I and II breast cancer: experiences at Osaka medical center for cancer and cardiovascular diseases. Breast Cancer 2002;9:248- 253
NIH Consensus Conference. Treatment of early stage breast cancer. JAMA 1991;265:391
Suh CO, Shin HS, Cho JH, et al. The 1998, 1999 patterns of care study for breast irradiation after breast conserving surgery in Korea. J Korean Soc Ther Radiol 2004;22:192- 199
Ministry of Health and Welfare. Republic of Korea. Annual report of the central cancer registry in Korea (2001.1- 2001.12), 2003
Halsted WS. A clinical and histological study of certain adenocarcinoma of the breast: and a brief consideration of the supraclavicular operation and of the results of operation for cancer of the breast from 1889 to 1898 at the Johns Hopkins Hospital. Ann Surg 1898;28:557- 576
Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6- 11
Jung SS, You YK, Park CH, Kim IC. Recent trends of breast cancer treatment in Korea. J Korean Surg Soc 1991; 41:717- 726
Ahn SH. Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg 2004;139:27- 30
Nattinger AB, Gottleib MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast conserving treatment for breast cancer. N Engl J Med 1992;326:1102
Gregorio DI, Kulldorff M, Barry L, et al. Geographical differences in primary therapy for early- stage breast cancer. Ann Surg Oncol 2001;8:844- 849
Samet JM, Hunt WC, Farrow DC. Determinants of receiving breast- conserving surgery. The surveillance, epidemiology, and end result program, 1983- 1986. Cancer 1994;73:2344
Shin HS, Lee HS, Chang SK, et al. The national survey of breast cancer treatment pattern in Korea (1998): the use of breast- conserving treatment. J Korean Soc Ther Radiol 2004; 22:184- 191
The Korean Breast Cancer Society. Nationwide Korean Breast Cancer data of 2002. J Korean Breast Cancer Society 2004;7:72- 83
Ahn SH, Yoo KY. The Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996- 2004. Breast Cancer Res Treat 2006;99:209- 214
Koh KH, Kim MS, Yoo SY, et al. The results of primary radiotherapy following breast- conserving surgery for early breast cancer. J Korean Soc Ther Radiol 1995;13:163- 172
Suh CO, Chung EJ, Lee HD, Lee KS, Oh KK, Kim GE. Risk factors for recurrence after conservative treatment in early breast cancer; preliminary report. J Korean Soc Ther Radiol 1997;15:331- 338
Hong SG, Lee JH, Lee SK, Yoon SO. Breast- conserving surgery with or without radiation therapy for eearly breast cancer. J Korean Surg Soc 1998;55:341- 349
Suh CO, Lee HD, Lee KS, Jung WH, Oh KK, Kim GE. Conservative surgery and primary radiotherapy for early breast cancer; Yonsei Cancer Center experience. J Korean Soc Ther Radiol 1994;12:337- 347
Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow- up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333: 11456- 11461
Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast- conserving surgery in small breast carcinoma: long- term results of a randomized trial. Ann Oncol 2001;12: 997- 1003
Recht A, Silen W, Schnitt SJ, et al. Time- course of local recurrence following conservative surgery and radiotherapy for early breast cancer. Int J Radiat Oncol Biol Phys 1988;15: 255- 261
Kim YS, Yoon SC, Chung SM, Ryu MR, Jung SS, Choi IB. Breast conservation therapy versus mastectomy- preliminary results of pattern of failure and survival rate in early breast cancer. J Korean Soc Ther Radiol 2004;22: 115- 123
Kim KJ, Huh SJ, Yang JH, et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005; 35:126- 133
Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast- conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003;56:658- 670
Ghossein NA, Alpert S, Barba J, et al. Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 1992;127:411- 415
Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 1997;43:73- 86
Osteen RT. Risk factors and management of local recurrence following breast conservation surgery. World J Surg 1995;18:76- 80
Levine MN, Pritchard KI, Bramwell VH, Shepherd LE, Tu D, Paul N. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node- positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5. J Clin Oncol 2005;23:5166- 5170
Mamounas EP, Bryant J, Lembersky B, et al. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node- positive breast cancer: results from NSABP B- 28. J Clin Oncol 2005;23:3686- 3696
Recht A, Come SE, Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early- stage, node positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 1991;9:1662- 1667
Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conserving surgery for early breast cancer. N England J Med 1996;334:1356- 1361
Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N England J Med 2004;351: 963- 970
Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node- positive breast cancer? Int J Radiat Oncol Biol Phys 2003;62:386- 391
※ AI-Helper는 부적절한 답변을 할 수 있습니다.